RYZ512

DIAGNOSTIC_TEST2 trials

Sponsors

RayzeBio, Inc., RayzeBio Inc.

Conditions

CancerMetastatic Clear Cell Renal Cell Carcinoma

Early Phase 1

Phase 0 Imaging Study of a CAIX Binder in Metastatic Clear Cell RCC.

Active, not recruitingPACTR202605495669702

RayzeBio Inc.Cancer

Start: 2026-06-01Target: 10Updated: 2026-08-03

Imaging Study in Metastatic Clear Cell RCC.

Not yet recruitingNCT07671417

RayzeBio, Inc.Metastatic Clear Cell Renal Cell Carcinoma

Start: 2026-06-01End: 2027-01-01Target: 10Updated: 2026-07-16